Omega Fund Management as of June 30, 2020
Portfolio Holdings for Omega Fund Management
Omega Fund Management holds 15 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Replimune Group Common Stock (REPL) | 36.1 | $132M | 5.3M | 24.73 | |
| Morphic Holding Common Stock (MORF) | 22.0 | $81M | 3.0M | 27.05 | |
| Gossamer Bio Common Stock (GOSS) | 11.8 | $43M | 3.3M | 13.00 | |
| Arcutis Biothereapeutics Common Stock (ARQT) | 7.0 | $26M | 845k | 30.24 | |
| Immunic Common Stock (IMUX) | 4.5 | $17M | 1.4M | 12.12 | |
| Paratek Pharmaceuticals Common Stock | 3.7 | $14M | 2.6M | 5.22 | |
| ESSA Pharma Common Stock (EPIX) | 2.5 | $9.3M | 1.5M | 6.20 | |
| Trevi Therapeutics Common Stock (TRVI) | 2.5 | $9.1M | 1.4M | 6.58 | |
| Beam Therapeutics Common Stock (BEAM) | 2.3 | $8.5M | 303k | 28.00 | |
| Cidara Therapeutics Common Stock | 2.0 | $7.4M | 2.0M | 3.69 | |
| ObsEva Common Stock | 1.6 | $5.9M | 999k | 5.89 | |
| FibroGen Common Stock (FGEN) | 1.4 | $5.3M | 131k | 40.53 | |
| Jounce Therapeutics Common Stock | 1.0 | $3.7M | 530k | 6.90 | |
| Prevail Therapeutics Common Stock | 0.8 | $2.8M | 188k | 14.90 | |
| Pieris Pharmaceuticals Common Stock | 0.6 | $2.3M | 751k | 3.10 |
